Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function
Cancers · 20.09.2023 · 15 (18) · 4653
DOI: 10.3390/cancers15184653 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 20.09.2023. Verfasst von Silvia Belluti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, AIRC (Fondazione Italiana per la Ricerca sul Cancro).
Abstract (Originalsprache)
Estrogens are almost ubiquitous steroid hormones that are essential for development, metabolism, and reproduction. They exert both genomic and non-genomic action through two nuclear receptors (ERα and ERβ), which are transcription factors with disregulated functions and/or expression in pathological processes. In the 1990s, the discovery of an additional membrane estrogen G-protein-coupled receptor augmented the complexity of this picture. Increasing evidence elucidating the specific molecular mechanisms of action and opposing effects of ERα and Erβ was reported in the context of prostate cancer treatment, where these issues are increasingly investigated. Although new approaches improved the efficacy of clinical therapies thanks to the development of new molecules targeting specifically estrogen receptors and used in combination with immunotherapy, more efforts are needed to overcome the main drawbacks, and resistance events will be a challenge in the coming years. This review summarizes the state-of-the-art on ERα and ERβ mechanisms of action in prostate cancer and promising future therapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
- Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Ospedale di Baggiovara, 41126 Modena, Italy.
ORCID-Profile: Silvia Belluti, Carol Imbriano, Livio Casarini
Förderung
- Italian Association for Cancer Research
- AIRC (Fondazione Italiana per la Ricerca sul Cancro)
Zitieren
APA
Belluti, S., Imbriano, C., & Casarini, L. (2023). Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function. Cancers, 15(18), 4653. https://doi.org/10.3390/cancers15184653
Vancouver
Belluti S, Imbriano C, Casarini L. Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function. Cancers. 2023;15(18):4653. doi:10.3390/cancers15184653
BibTeX
@article{Belluti2023,
author = {Belluti, Silvia and Imbriano, Carol and Casarini, Livio},
title = {Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function},
journal = {Cancers},
year = {2023},
volume = {15},
number = {18},
pages = {4653},
doi = {10.3390/cancers15184653}
}
EUVIMED